DalCor Pharmaceuticals US, LLC, 2026-08-28
A new SEC Form D private-offering notice from Sarasota, FL, a $6,958,236 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing dalcetrapib, a precision medicine for cardiovascular disease targeting a specific genetic subset of patients
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- StrataBio Inc., 2026-08-31, $500K, Tallahassee, FL
- Candor Therapeutics Inc., 2026-08-28, $750K, Sunnyvale, CA
- Camelato, Inc., 2026-08-28, $250K, North Miami Beach, FL
- Monocacy Therapeutics Inc., 2026-08-28, $150K, Monrovia, MD
- Dynamic Experts, Inc., 2026-08-28, $1M, Boca Raton, FL
- Aegle Therapeutics Corp, 2026-08-28, $2.3M, Woburn, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.